U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C44H58N8O5S
Molecular Weight 811.047
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0
Stereo Comments AXIAL, R

SHOW SMILES / InChI
Structure of Daraxonrasib

SMILES

CCN1C2=C3C=C(C=C2)C4=CSC(C[C@H](NC(=O)[C@H]5C[C@@H]5C)C(=O)N6CCC[C@H](N6)C(=O)OCC(C)(C)CC3=C1C7=CC(=CN=C7[C@H](C)OC)N8CCN(C)CC8)=N4

InChI

InChIKey=FVICRBSEYSHKFY-JYQNNKODSA-N
InChI=1S/C44H58N8O5S/c1-8-51-37-12-11-28-19-31(37)33(40(51)32-20-29(23-45-39(32)27(3)56-7)50-16-14-49(6)15-17-50)22-44(4,5)25-57-43(55)34-10-9-13-52(48-34)42(54)35(21-38-46-36(28)24-58-38)47-41(53)30-18-26(30)2/h11-12,19-20,23-24,26-27,30,34-35,48H,8-10,13-18,21-22,25H2,1-7H3,(H,47,53)/t26-,27-,30-,34-,35-/m0/s1

HIDE SMILES / InChI

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
503.7 nM
400 mg 1 times / day steady-state, oral
dose: 400 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
RMC-6236 blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
7131 nM × h
400 mg 1 times / day steady-state, oral
dose: 400 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
RMC-6236 blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
8.1 h
400 mg 1 times / day steady-state, oral
dose: 400 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
RMC-6236 blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
2.3%
unknown
RMC-6236 plasma
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Name Type Language
Daraxonrasib
Common Name English
(1S,2S)-N-[(12<sup>M</sup>,4S,6<sup>3</sup>S)-1<sup>1</sup>-ethyl-12-{2-[(1S)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)pyridin-3-yl}-10,10-dimethyl-5,7-dioxo-1<sup>1</sup>H-8-oxa-1(5,3)-indola-6(1,3)-[1,2]diazinana-2(4,2)-[1,3]thiazolacycloundecaphan-4-
Preferred Name English
Cyclopropanecarboxamide, N-[(2R,14S,18S)-1-ethyl-18,19,20,21-tetrahydro-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl
Common Name English
daraxonrasib [INN]
Common Name English
Code System Code Type Description
INN
13270
Created by admin on Wed Apr 02 10:30:03 GMT 2025 , Edited by admin on Wed Apr 02 10:30:03 GMT 2025
PRIMARY
FDA UNII
B6T47Y2UAP
Created by admin on Wed Apr 02 10:30:03 GMT 2025 , Edited by admin on Wed Apr 02 10:30:03 GMT 2025
PRIMARY
CAS
2765081-21-6
Created by admin on Wed Apr 02 10:30:03 GMT 2025 , Edited by admin on Wed Apr 02 10:30:03 GMT 2025
PRIMARY
PUBCHEM
164726578
Created by admin on Wed Apr 02 10:30:03 GMT 2025 , Edited by admin on Wed Apr 02 10:30:03 GMT 2025
PRIMARY